Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent
Sponsor: Swiss Vision Network
Listed as NCT03151577, this NA trial focuses on Glaucoma and Glaucoma, Angle-Closure and remains ongoing. Sponsored by Swiss Vision Network, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.
Follow-up period is 2 years.
To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.
Follow-up period is 2 years.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Swiss Vision Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.